QQQ   431.80 (+0.17%)
AAPL   169.74 (-1.71%)
MSFT   416.09 (+0.59%)
META   501.05 (+0.16%)
GOOGL   154.93 (+0.05%)
AMZN   183.84 (+0.12%)
TSLA   157.21 (-2.64%)
NVDA   876.93 (+1.97%)
AMD   163.60 (+2.05%)
NIO   3.84 (-1.29%)
BABA   69.93 (-0.98%)
T   16.06 (-1.11%)
F   12.15 (-0.65%)
MU   122.14 (+0.63%)
GE   156.40 (+1.76%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.80 (+13.36%)
PFE   25.77 (-0.54%)
PYPL   63.63 (+0.19%)
XOM   118.77 (-0.76%)
QQQ   431.80 (+0.17%)
AAPL   169.74 (-1.71%)
MSFT   416.09 (+0.59%)
META   501.05 (+0.16%)
GOOGL   154.93 (+0.05%)
AMZN   183.84 (+0.12%)
TSLA   157.21 (-2.64%)
NVDA   876.93 (+1.97%)
AMD   163.60 (+2.05%)
NIO   3.84 (-1.29%)
BABA   69.93 (-0.98%)
T   16.06 (-1.11%)
F   12.15 (-0.65%)
MU   122.14 (+0.63%)
GE   156.40 (+1.76%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.80 (+13.36%)
PFE   25.77 (-0.54%)
PYPL   63.63 (+0.19%)
XOM   118.77 (-0.76%)
QQQ   431.80 (+0.17%)
AAPL   169.74 (-1.71%)
MSFT   416.09 (+0.59%)
META   501.05 (+0.16%)
GOOGL   154.93 (+0.05%)
AMZN   183.84 (+0.12%)
TSLA   157.21 (-2.64%)
NVDA   876.93 (+1.97%)
AMD   163.60 (+2.05%)
NIO   3.84 (-1.29%)
BABA   69.93 (-0.98%)
T   16.06 (-1.11%)
F   12.15 (-0.65%)
MU   122.14 (+0.63%)
GE   156.40 (+1.76%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.80 (+13.36%)
PFE   25.77 (-0.54%)
PYPL   63.63 (+0.19%)
XOM   118.77 (-0.76%)
QQQ   431.80 (+0.17%)
AAPL   169.74 (-1.71%)
MSFT   416.09 (+0.59%)
META   501.05 (+0.16%)
GOOGL   154.93 (+0.05%)
AMZN   183.84 (+0.12%)
TSLA   157.21 (-2.64%)
NVDA   876.93 (+1.97%)
AMD   163.60 (+2.05%)
NIO   3.84 (-1.29%)
BABA   69.93 (-0.98%)
T   16.06 (-1.11%)
F   12.15 (-0.65%)
MU   122.14 (+0.63%)
GE   156.40 (+1.76%)
CGC   6.73 (-3.58%)
DIS   113.85 (+0.80%)
AMC   2.80 (+13.36%)
PFE   25.77 (-0.54%)
PYPL   63.63 (+0.19%)
XOM   118.77 (-0.76%)
NASDAQ:DOMH

Dominari (DOMH) Stock Price, News & Analysis

$2.85
-0.08 (-2.73%)
(As of 02:47 PM ET)
Today's Range
$2.78
$2.90
50-Day Range
$1.95
$3.14
52-Week Range
$1.76
$3.76
Volume
8,517 shs
Average Volume
12,004 shs
Market Capitalization
$16.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Dominari MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.27mentions of Dominari in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$90,278 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.49 out of 5 stars

Medical Sector

729th out of 930 stocks

Security Brokers & Dealers Industry

23rd out of 26 stocks

DOMH stock logo

About Dominari Stock (NASDAQ:DOMH)

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

DOMH Stock Price History

DOMH Stock News Headlines

Your eBook: Mastering Earnings Announcements Trading
Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).
Your eBook: Mastering Earnings Announcements Trading
Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).
Thursday 4/6 Insider Buying Report: PL, DOMH
Kyle Wool Named CEO of Dominari Financial
See More Headlines
Receive DOMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/16/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Security brokers & dealers
Sub-Industry
N/A
Current Symbol
NASDAQ:DOMH
Web
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-22,880,000.00
Pretax Margin
-1,122.22%

Debt

Sales & Book Value

Annual Sales
$2.04 million
Book Value
$9.90 per share

Miscellaneous

Free Float
5,357,000
Market Cap
$16.54 million
Optionable
Not Optionable
Beta
0.91
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

DOMH Stock Analysis - Frequently Asked Questions

How have DOMH shares performed in 2024?

Dominari's stock was trading at $2.59 at the beginning of the year. Since then, DOMH stock has increased by 7.7% and is now trading at $2.79.
View the best growth stocks for 2024 here
.

Are investors shorting Dominari?

Dominari saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 2,300 shares, a decrease of 42.5% from the March 15th total of 4,000 shares. Based on an average daily trading volume, of 12,300 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.1% of the shares of the stock are sold short.
View Dominari's Short Interest
.

When is Dominari's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our DOMH earnings forecast
.

How do I buy shares of Dominari?

Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DOMH) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners